{"nct_id":"NCT02203032","title":"A Study of Guselkumab in Participants With Moderate to Severe Plaque-type Psoriasis and an Inadequate Response to Ustekinumab","status":"COMPLETED","status_verified_date":"2017-08","start_date":"2014-10-07","start_date_type":"ACTUAL","primary_completion_date":"2015-12-25","primary_completion_date_type":"ACTUAL","completion_date":"2016-05-24","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["JNJ"]}